LRMR · Larimar Therapeutics, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“these cash resources are not sufficient to fund the Company's planned operations for a period of at least one year from the date these unaudited condensed consolidated financial statements are issued. ... There is no assurance, however, that additional financing will be available when needed or that the Company will be able to obtain financing on terms acceptable to the Company. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern.”